MarketScreener Homepage > Equities > Hong Kong Stock Exchange > China Medical System Holdings Limited 867 KYG211081248

Report

End-of-day quote Hong Kong Stock Exchange - 01/22
10.22	HKD		-2.48%

01/19

CHINA MEDICAL SYSTEM : Shares Jump 7% on Regulatory Nod for Clinical Trial of Anemia Drug

2020

CHINA MEDICAL SYSTEM : 00867.HK) MSCI-ESG Rating Upgraded to AA

2020

CHINA MEDICAL SYSTEM : 00867.HK)'s MSCI-ESG Rating Upgraded to "AA", Reaching the Global Leading Level

Summary

Quotes 5-day view End-of-day quote.

End-of-day quote Hong Kong Stock Exchange

01/18/2021	01/19/2021	01/20/2021	01/21/2021	01/22/2021	Date
9.62	9.89	10.38	10.48	10.22	Last
5517000	7401604	9271898	11929730	6256800	Volume
+3.33%	+2.81%	+4.95%	+0.96%	-2.48%	Change

Financials

Sales 2020	6 573 M 1 014 M 1 014 M
Net income 2020	2 377 M 367 M 367 M
Net cash position 2020	1 529 M 236 M 236 M
P/E ratio 2020	8,96x
Yield 2020	4,15%

Sales 2021	7 253 M 1 119 M 1 119 M
Net income 2021	2 584 M 399 M 399 M
Net cash position 2021	2 739 M 423 M 423 M
P/E ratio 2021	8,28x
Yield 2021	4,44%

Capitalization	21 111 M 3 257 M 3 257 M
EV / Sales 2020	2,98x
EV / Sales 2021	2,53x
Nbr of Employees	4 147
Free-Float	50,8%

More Financials

Company

China Medical System Holdings Limited is a Hong Kong-based investment holding company principally engaged in the manufacture, marketing, promotion and sales of pharmaceutical products. Its main products under direct network include Deanxit, Ursofalk, XinHuoSu, Salofalk, Bioflor and Augentropfen Stulln Mono Eye-drops, among others. Its products under the agency promotion network include ShaDuoLiKa, YiNuoShu and...

Sector

Pharmaceuticals

Calendar

03/22

Earnings Release

More about the company

Notations Surperformance© of China Medical System Holdings Limited

Trading Rating :

Investor Rating :

More Ratings

All news about CHINA MEDICAL SYSTEM HOLDINGS LIMITED

01/19	CHINA MEDICAL SYSTEM : Shares Jump 7% on Regulatory Nod for Clinical Trial of An..	MT
2020	CHINA MEDICAL SYSTEM : 00867.HK) MSCI-ESG Rating Upgraded to AA	AQ
2020	CHINA MEDICAL SYSTEM : 00867.HK)'s MSCI-ESG Rating Upgraded to "AA", Reaching th..	AQ
2020	COSMO PHARMACEUTICALS N : announces licence of Lumeblue China rights to China Me..	AQ
2020	Cosmo Pharmaceuticals Signs License Deal in China for Colonoscopy Lesions Dru..	MT
2020	China Medical System Strikes Deal to Distribute UK Pharma's Diagnostic Drug i..	MT
2020	CHINA MEDICAL SYSTEM : Voluntary and Business Update Announcement Related to Sig..	PU
2020	CHINA MEDICAL SYSTEM HOLDINGS LIMITE : Ex-dividend day for interim dividend	FA
2020	CHINA MEDICAL SYSTEM HOLDINGS LIMITE : half-yearly earnings release
2020	CHINA MEDICAL SYSTEM : Voluntary and Business Update Announcement Tildrakizumab ..	PU
2020	CHINA MEDICAL SYSTEM HOLDINGS LIMITE : 2020 Interim Results Announcement	AQ
2020	CHINA MEDICAL SYSTEM : Interim results announcement for the six months ended 30 ..	PU
2020	CHINA MEDICAL SYSTEM : Terms of Reference of the Remuneration Committee	PU
2020	CHINA MEDICAL SYSTEM : Terms of Reference of the Nomination Committee	PU
2020	CHINA MEDICAL SYSTEM HOLDINGS LIMITE : Ex-dividend day for final dividend	FA

More news

News in other languages on CHINA MEDICAL SYSTEM HOLDINGS LIMITED

2020	Cosmo cède les droits de licence pour Lumeblue en Chine à CMS
2020	Cosmo vergibt China-Lizenz für Methylenblau an China Medical System
2020	CHINA MEDICAL SYSTEM HOLDINGS LIMITE : Veröffentlichung des Halbjahresergebnisse..
2020	CHINA MEDICAL SYSTEM HOLDINGS LIMITE : publication des résultats semestriels
2020	Hong Kong-Lam nommera les juges de la sécurité nationale sur recommandations

More news

Provided by Scoopnest.com

Chart CHINA MEDICAL SYSTEM HOLDINGS LIMITED

Duration : Period :

China Medical System Holdings Limited Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends CHINA MEDICAL SYSTEM HOLDINGS LIMITED

	Short Term	Mid-Term	Long Term
Trends	Bullish	Bullish	Neutral

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	OUTPERFORM
Number of Analysts	8
Average target price	10,38 CNY
Last Close Price	8,54 CNY
Spread / Highest target	61,4%
Spread / Average Target	21,4%
Spread / Lowest Target	1,31%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Kong Lam	Chairman, President & Chief Executive Officer
Hong Bing Chen	Chief Operating Officer, Executive Director & VP
Yan Ling Chen	Chief Financial Officer, Executive Director & VP
Wai Ming Wong	Chief Technical Officer
Chi Keung Wu	Independent Non-Executive Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

CHINA MEDICAL SYSTEM HOLDINGS LIMITED	18.01%	3 257



OTSUKA HOLDINGS CO., LTD.	-0.11%	23 059
SUN PHARMACEUTICAL INDUSTRIES LTD.	-2.90%	18 909
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.	-4.17%	18 748
ONO PHARMACEUTICAL CO., LTD.	-1.71%	14 692
ZHEJIANG NHU COMPANY LTD.	21.59%	13 575

More Results